Results 131 to 140 of about 1,634,119 (336)

Enhanced Hemocompatibility via Bivalirudin and Bicarbonate as Alternative to Heparin in a Catheter‐Based Axial‐Flow System

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Cardiovascular therapeutic devices typically require systemic heparin due to underlying thrombotic risk. The Impella axial flow system further relies on internal perfusion with either a heparin‐containing or sodium bicarbonate purge solution during operation.
Kaitlyn R. Ammann   +7 more
wiley   +1 more source

A Road Less Traveled: Successful Alcohol Septal Ablation via an Aberrant Septal Coronary Artery in Hypertrophic Obstructive Cardiomyopathy

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Alcohol septal ablation (ASA) is a minimally invasive treatment option for patients with hypertrophic obstructive cardiomyopathy (HOCM) who remain symptomatic despite medical treatment and are either poor surgical candidates or prefer a less invasive approach.
Vishnu Bharani   +3 more
wiley   +1 more source

Reduction of acute myocardial infarction (AMI) hospital admissions in the region of Messinia in Greece during the COVID-19 lockdown period

open access: yesHellenic Journal of Cardiology, 2021
Emmanouil Makaris   +9 more
doaj  

Intravascular Lithotripsy for Calcific Coronary Bifurcations: Procedural Success and 1‐Year Clinical Outcomes

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Intravascular lithotripsy (IVL) has emerged as a promising treatment for heavily calcified coronary lesions. However, evidence regarding its effectiveness in calcific bifurcation lesions remains limited. Objective We aimed to evaluate the technical success and 1‐year clinical outcomes of IVL in calcified coronary bifurcation lesions.
Federico Oliveri   +15 more
wiley   +1 more source

Management of Lost Atherectomy Devices in the Coronary Arteries

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Rotational and orbital atherectomy are important tools to treat calcific coronary disease. Entrapment of an atherectomy device, that is, rotational atherectomy burr or orbital atherectomy crown, is a serious complication during atherectomy. Loss of an atherectomy device is a more challenging complication that usually follows device entrapment.
Gregor Leibundgut   +8 more
wiley   +1 more source

Long‐Term Durability of Transcatheter Aortic Valves in Patients With Bicuspid Aortic Stenosis

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Data concerning the long‐term durability of transcatheter aortic valves (TAVs) in patients with bicuspid aortic stenosis (AS) are lacking. Aims The study aims to report data on long‐term valve durability following transcatheter aortic valve replacement (TAVR) in bicuspid AS.
Yuheng Jia   +46 more
wiley   +1 more source

Severe Vasoplegic Syndrome Treated with Angiotensin II and Hemoadsorption Therapy after Cardiac Surgery

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Vasoplegic syndrome (VS) is a common complication after cardiac surgery with cardiopulmonary bypass (CPB). The main pathophysiology mechanism of VS includes a systemic inflammatory response syndrome due to surgical trauma, release of pro‐inflammatory mediators caused by blood contact with foreign surfaces of heart‐lung machine (pump and tubing)
Matteo Lucchelli   +3 more
wiley   +1 more source

Drug Coated Balloons Versus Drug‐Eluting Stents in Patients With De Novo Coronary Artery Disease

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background In patients with de novo coronary artery disease (CAD), percutaneous coronary intervention (PCI) with drug eluting stent (DES) implantation is the gold standard therapy. New evidence is available with drug coated balloons (DCB) angioplasty. The objective of this meta‐analysis was to compare the efficacy and safety of DCB angioplasty
Daniel O'Callaghan   +9 more
wiley   +1 more source

Progress in Pharmacogenomics Implementation in the United States: Barrier Erosion and Remaining Challenges

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Barriers to incorporating pharmacogenetics into routine clinical practice in the United States are well documented. Initial surveys by the Clinical Pharmacogenetics Implementation Consortium (CPIC) in 2009 and 2010 identified barriers across four key domains that have hindered the widespread adoption of clinical pharmacogenetic testing.
D. Max Smith   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy